Merck & Co Newsroom

Merck (MRK.US) / Kelun Biotech's ADC therapy has received breakthrough therapy designation from the FDA for the treatment of non-small cell lung cancer.

Previously, merck (MRK.US) reached a cooperation agreement with CStone Pharmaceuticals (06990), granting merck exclusive rights to develop, produce, and commercialize Sac-TMT outside the greater China region.

Zhitong Finance02:27 ET

Electronic Arts, Lyft and 7 More Stocks That Can Benefit From Trump's R&D Policy

Barrons02:00 ET

Express News | Merck & Co Inc : HSBC Raises to Buy From Hold

Reuters01:55 ET

Merck & Co., Inc. (MRK) 7th Annual Evercore ISI HealthCONx Conference (Transcript)

Earnings Call Transcripts17:41 ET

Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today

Kevin Travers16:20 ET

Nasdaq, S&P Ebb Near Record Highs, Dow Slips as JOLTS Report Kicks off Run of Jobs Data

Seeking Alpha11:46 ET

Express News | Former Merck USA President Joins Klotho Neurosciences’ Board of Directors

Reuters11:00 ET

Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock

Kevin TraversDec 3 10:27 ET

Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance

BenzingaDec 3 09:16 ET

Merck & Co., Inc.'s (NYSE:MRK) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Simply Wall StDec 3 08:33 ET

Merck Say Lung Cancer Treatment Receives FDA Breakthrough Therapy Designation

MT NewswiresDec 3 07:55 ET

Express News | FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (Sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With Egfr Mutations

ReutersDec 3 06:45 ET

S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today

Kevin TraversDec 2 16:25 ET

Merck & Co Unusual Options Activity For December 02

BenzingaDec 2 15:45 ET

Bernstein Maintains Merck & Co(MRK.US) With Hold Rating, Cuts Target Price to $110

Moomoo NewsDec 2 15:31 ET · Ratings

Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump

BenzingaDec 2 11:19 ET

December Starts With a Mixed Market | Live Stock

Kevin TraversDec 2 11:13 ET

Bernstein Trims Price Target on Merck to $110 From $115

MT NewswiresDec 2 06:24 ET · Ratings

Merck (MRK.US) antibiotic combination has been approved for sale in China.

Merck (MRK.US) antibiotic combination has been approved for sale in China.

Zhitong FinanceDec 2 02:16 ET

Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings

Seeking AlphaNov 29 12:00 ET